23andMe Sells Gene-Testing Business to DNA Drug Maker Regeneron - Bloomberg
bloomberg.com
•
Business
•
World
Bankrupt 23andMe sold its extensive DNA database to Regeneron Pharmaceuticals for $256 million, ensuring data privacy under Regeneron's commitment to existing customer policies.